Bromhexine

Identification

Name
Bromhexine
Accession Number
DB09019
Description

Bromhexine is an expectorant/mucolytic agent. Bromhexine is not available in the United States. It is marketed under the trade name Bisolvon(R) in Germany, England, Belgium, France, Italy, Netherlands, Norway, Sweden, Australia, and South Africa.

Type
Small Molecule
Groups
Approved
Structure
Thumb
Weight
Average: 376.13
Monoisotopic: 373.999323944
Chemical Formula
C14H20Br2N2
Synonyms
  • 3,5-dibromo-N(alpha)-cyclohexyl-N(alpha)-methyltoluene-alpha-2-diamine
  • Bromexina
  • Bromhexina
  • Bromhexine
  • Bromhexinum
  • N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)amine
External IDs
  • NA 274

Pharmacology

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Indication
Not Available
Associated Conditions
Associated Therapies
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Product Ingredients
IngredientUNIICASInChI Key
Bromhexine hydrochlorideYC2ZOM3Z8V611-75-6UCDKONUHZNTQPY-UHFFFAOYSA-N
International/Other Brands
Amiorel (Boehringer Ingelheim) / Bisolmed (Boehringer Ingelheim) / Bisolvon (Boehringer Ingelheim) / Bisolvon Chesty (Boehringer Ingelheim) / Fluibron
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
BROMHEXINE ELIXIRElixir4 mg/5mlOralบริษัท พาตาร์แลบ (2517) จำกัด จำกัด2013-05-08Not applicableThailand flag
BROMXINETablet8 mgOralบริษัท โรงงานเภสัชกรรมแอตแลนติค จำกัด1987-06-15Not applicableThailand flag
คอนเฮกซินSyrup4 mg/5mlOralบริษัท คอนติเนนเติล-ฟาร์ม จำกัด จำกัด1998-03-18Not applicableThailand flag
ดูทรอสTablet8 mgOralบริษัท ไทยนครพัฒนา จำกัด1996-03-26Not applicableThailand flag
ดูทรอสSyrup4 mg/5mlOralบริษัท ไทยนครพัฒนา จำกัด1997-12-10Not applicableThailand flag
บรอนมูคอนTablet8 mgOralห้างหุ้นส่วนจำกัด สุพงษ์เภสัช1983-06-28Not applicableThailand flag
บรอนเคลีย ชนิดเม็ดTablet8 mgOralบริษัท โปลิฟาร์ม จำกัด จำกัด1985-08-20Not applicableThailand flag
บรอนเคส ชนิดน้ำเชื่อมSyrup4 mg/5mlOralบริษัท โรงงานผลิตเวชภัณฑ์ชินต้าเทรดดิ้ง (1971) จำกัด จำกัด2000-06-06Not applicableThailand flag
บรอมซิดอน อิลิกซ์เซอร์SolutionOralบริษัท โรงงานเภสัชอุตสาหกรรม เจเอสพี (ประเทศไทย) จำกัด (มหาชน)2020-03-17Not applicableThailand flag
บรอมซิน ไซรัปSyrup4 mg/5mlOralบริษัท ยูเมด้า จำกัด2000-12-18Not applicableThailand flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ROBITUSSIN MEBromhexine (4 MG/5ML) + Guaifenesin (100 MG/5ML)SyrupOralบริษัท แกล็กโซสมิทไคล์น คอนซูมเมอร์ เฮลธ์แคร์ (ประเทศไทย) จำกัด2020-06-10Not applicableThailand flag
คูป้าBromhexine hydrochloride (4 mg) + Guaifenesin (100 mg)Tabletบริษัท เอ็ม แอนด์ เอ็ช แมนูแฟคเจอริ่ง จำกัด1988-03-22Not applicableThailand flag
ดูทรอส เอ็กซ์Bromhexine hydrochloride (4 mg/5mL) + Potassium guaiacolsulfonate (200 mg/5mL)Syrupบริษัท ไทยนครพัฒนา จำกัด2013-02-06Not applicableThailand flag
ทอไกลโคโล่Bromhexine hydrochloride (2 mg/5mL) + Potassium guaiacolsulfonate (200 mg/5mL)Syrupบริษัท สยามเภสัช จำกัด1985-09-17Not applicableThailand flag
ทอไกลโคโล่ ชนิดเม็ดBromhexine hydrochloride (4 mg) + Guaifenesin (100 mg)Tabletบริษัท สยามเภสัช จำกัด1987-04-21Not applicableThailand flag
เอ็กซ์โทแรนท์Bromhexine hydrochloride (4 mg) + Guaifenesin (100 mg)Tabletบริษัท เคนยากุ (ประเทศไทย) จำกัด1985-06-15Not applicableThailand flag
ไบโซลวอน เอ็กซ์Bromhexine (4 MG/5ML) + Guaifenesin (100 MG/5ML)SyrupOralบริษัท ซาโนฟี่-อเวนตีส (ประเทศไทย) จำกัด2017-03-18Not applicableThailand flag

Categories

ATC Codes
R05CB02 — Bromhexine
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as phenylmethylamines. These are compounds containing a phenylmethtylamine moiety, which consists of a phenyl group substituted by an methanamine.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Phenylmethylamines
Direct Parent
Phenylmethylamines
Alternative Parents
Benzylamines / 2-bromoanilines / Cyclohexylamines / Bromobenzenes / Aralkylamines / Aryl bromides / Trialkylamines / Primary amines / Organopnictogen compounds / Organobromides
show 1 more
Substituents
2-bromoaniline / Amine / Aniline or substituted anilines / Aralkylamine / Aromatic homomonocyclic compound / Aryl bromide / Aryl halide / Benzylamine / Bromobenzene / Cyclohexylamine
show 11 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
organobromine compound, tertiary amino compound, substituted aniline (CHEBI:77032)

Chemical Identifiers

UNII
Q1J152VB1P
CAS number
3572-43-8
InChI Key
OJGDCBLYJGHCIH-UHFFFAOYSA-N
InChI
InChI=1S/C14H20Br2N2/c1-18(12-5-3-2-4-6-12)9-10-7-11(15)8-13(16)14(10)17/h7-8,12H,2-6,9,17H2,1H3
IUPAC Name
2,4-dibromo-6-{[cyclohexyl(methyl)amino]methyl}aniline
SMILES
CN(CC1=CC(Br)=CC(Br)=C1N)C1CCCCC1

References

Synthesis Reference

U.S. Patent 3,336,308.

General References
  1. NPRA Product Information: Salmodil (salbutamol sulfate/bromhexine hydrochloride) oral syrup [Link]
  2. NPRA Product Information: Rexom Unizet (diphenhydramine hydrochloride/bromhexine hydrochloride/ammonium chloride) oral syrup [Link]
KEGG Drug
D07542
PubChem Compound
2442
PubChem Substance
310264976
ChemSpider
2348
BindingDB
50239965
RxNav
1753
ChEBI
77032
ChEMBL
CHEMBL253376
ZINC
ZINC000000608220
Drugs.com
Drugs.com Drug Page
Wikipedia
Bromhexine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedPreventionCoronavirus Disease 2019 (COVID‑19) / Increased Risk of SARS-CoV-2 Infection1
4RecruitingTreatmentCoronavirus Disease 2019 (COVID‑19)1
3RecruitingTreatmentAbnormal Mucus Secretions / Respiratory Tract Diseases1
3RecruitingTreatmentCoronavirus Disease 2019 (COVID‑19) / COVID 191
1Not Yet RecruitingTreatmentPharmacokinetics1
0Enrolling by InvitationPreventionAntimalarials / Antirheumatic Agents / Coronavirus Disease 2019 (COVID‑19) / Enzyme Inhibitors / Hydroxychloroquine1
Not AvailableActive Not RecruitingTreatmentCoronavirus Disease 2019 (COVID‑19) / Novel Coronavirus Pneumonia1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Granule8 MG
InjectionIntramuscular; Intravenous2 MG/ML
Injection, solution4 MG/2ML
SuppositoryRectal16 MG
SuppositoryRectal8 MG
SolutionOral2 mg/ml
SolutionOral4 mg/5ml
SolutionOral8 MG/5ML
TabletOral8 mg/1
SolutionRespiratory (inhalation)0.2 g
Tablet, solubleOral8 mg
SyrupOral150 mg/5mL
Tablet150 mg
SyrupOral7.5 mg
SolutionOral80 mg
SyrupOral4 mg/5ml
TabletOral8 mg
SyrupOral200 ml
Tablet, sugar coatedOral8 mg/1
SolutionOral
TabletOral12 MG
SolutionOral12 MG/ML
SolutionOral8 MG/ML
SyrupOral0.16 g
SyrupOral0.08 g
PowderNot applicable1000 g/1000g
SyrupOral0.04 g
TabletOral4 MG
CreamOral; Vaginal80 mg
SyrupOral100 ml
SyrupOral8 MG/5ML
SyrupOral50 mg
ElixirOral8 MG/5ML
SolutionOral0.8 mg/ml
Tablet8 mg
ElixirOral4 mg/5ml
Capsule, liquid filledOral8 mg
SolutionOral160 mg
SyrupOral
InjectionIntramuscular; Intravenous4 mg/2ml
SyrupOral80 mg
SyrupOral40 mg
SolutionOral0.16 g
SyrupOral160 mg
SolutionOral0.08 g
SyrupOral150 mg
SyrupOral2 mg/5ml
Tablet, film coatedOral8 MG
SolutionOral0.04 g
Tablet, sugar coatedOral
Capsule
Capsule
Solution
Syrup
Tablet
Tablet, film coated
SyrupOral
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)232-235U.S. Patent 3,336,308.
Predicted Properties
PropertyValueSource
Water Solubility0.00362 mg/mLALOGPS
logP4.08ALOGPS
logP4.42ChemAxon
logS-5ALOGPS
pKa (Strongest Acidic)19.89ChemAxon
pKa (Strongest Basic)9.32ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area29.26 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity85.56 m3·mol-1ChemAxon
Polarizability32.98 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-03di-0095000000-2c4f15e31beb22fd1178
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-03di-0090000000-4d3be1605bfa79609959
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-03di-0090000000-428c05c13a2a9e326945
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-03di-0390000000-b0ece5d5d6f8b78af198

Drug created on June 24, 2014 16:22 / Updated on February 21, 2021 18:52